Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study.
Eur Urol
2022
82
1
22-30
[Do's and Dont's for radical cystectomy and urinary diversion - how to minimise postoperative complications].
Aktuelle Urol
2022
53
2
159-166
[Metastatic urothelial carcinoma-guideline-based therapy and new options].
Urologe A
2022
61
3
265-272
International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.
Urolithiasis
2022
51
1
European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Percutaneous Nephrolithotomy.
Eur Urol Focus
2022
8
2
588-597
["Surgery only" is not enough: potential of multimodal therapy in urothelial bladder carcinoma].
Urologie
2022
61
12
1332-1340
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study.
J Nucl Med
2022
63
11
1651-1658
MHC I Expression Predicts Response to Checkpoint Inhibitors in Metastatic Urothelial Carcinoma but Lacks Prognostic Value in Localized Disease
Bladder Cancer
2022
8
3
269-276
Role of immunotherapy in perioperative treatment of localized muscle-invasive urothelial cancer
Onkologie
2022
28
9
782-791